크론병에서 복잡성 항문주위 샛길의 수술적 치료

키워드

참고문헌 (43)

1. Molodecky NA, "Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review", Gastroenterology, 142, pp.46~54 (2012)
2. Yang SK, "Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study", Inflamm Bowel Dis, 14, pp.542~549 (2008)
3. Kappelman MD, "The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States", Clin Gastroenterol Hepatol, 5, pp.1424~1429 (2007)
4. Hellers G, "Occurrence and outcome after primary treatment of anal fistulae in Crohn’s disease", Gut, 21, pp.525~527 (1980)
5. Schwartz DA, "The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota", Gastroenterology, 122, pp.875~880 (2002)
6. Eglinton TW, "The spectrum of perianal Crohn’s disease in a population-based cohort", Dis Colon Rectum, 55, pp.773~777 (2012)
7. Kamm MA, "Perianal fistulizing Crohn’s disease: a call to action", Clin Gastroenterol Hepatol, 6, pp.7~10 (2008)
8. Dejaco C, "Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn’s disease", Aliment Pharmacol Ther, 18, pp.1113~1120 (2003)
9. Soon SY, "Experience with the use of low-dose methotrexate for inflammatory bowel disease", Eur J Gastroenterol Hepatol, 16, pp.921~926 (2004)
10. Sands BE, "Infliximab maintenance therapy for fistulizing Crohn’s disease", N Engl J Med, 350, pp.876~885 (2004)
11. Hanauer SB, "Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial", Gastroenterology, 130, pp.323~333 (2006)
12. Sandborn WJ, "Certolizumab pegol for the treatment of Crohn’s disease", N Engl J Med, 357, pp.228~238 (2007)
13. Geltzeiler CB, "Recent developments in the surgical management of perianal fistula for Crohn’s disease", Ann Gastroenterol, 27, pp.320~330 (2014)
14. Haennig A, "The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn’s disease", Colorectal Dis, 17, pp.311~319 (2015)
15. García-Olmo D, "Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn’s disease: a new cell-based therapy", Int J Colorectal Dis, 18, pp.451~454 (2003)
16. Parks AG, "A classification of fistula-in-ano", Br J Surg, 63, pp.1~12 (1976)
17. Bell SJ, "The clinical course of fistulating Crohn’s disease", Aliment Pharmacol Ther, 17, pp.1145~1151 (2003)
18. Sandborn WJ, "AGA technical review on perianal Crohn’s disease", Gastroenterology, 125, pp.1508~1530 (2003)
19. Gecse KB, "A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease", Gut, 63, pp.1381~1392 (2014)
20. Papaconstantinou I, "Surgical management of fistula-in-ano among patients with Crohn’s disease: analysis of outcomes after fistulotomy or seton placement-single-center experience", Scand J Surg, 106, pp.211~215 (2017)
21. Koganei K, "Seton treatment for perianal Crohn’s fistulas", Surg Today, 25, pp.32~36 (1995)
22. Thornton M, "Long-term indwelling seton for complex anal fistulas in Crohn’s disease", Dis Colon Rectum, 48, pp.459~463 (2005)
23. Kotze PG, "Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn’s disease: a Brazilian multicenter observational study", Arq Gastroenterol, 51, pp.284~289 (2014)
24. Kodner IJ, "Endorectal advancement flap repair of rectovaginal and other complicated anorectal fistulas", Surgery, 114, pp.682~689 (1993)
25. Göttgens KW, "Treatment of Crohn’s disease-related high perianal fistulas combining the mucosa advancement flap with platelet-rich plasma: a pilot study", Tech Coloproctol, 19, pp.455~459 (2015)
26. Venkatesh KS, "Fibrin glue application in the treatment of recurrent anorectal fistulas", Dis Colon Rectum, 42, pp.1136~1139 (1999)
27. Romanos GE, "Effect of Tissucol on connective tissue matrix during wound healing: an immunohistochemical study in rat skin", J Biomed Mater Res, 39, pp.462~468 (1998)
28. Vitton V, "Long-term healing of Crohn’s anal fistulas with fibrin glue injection", Aliment Pharmacol Ther, 21, pp.1453~1457 (2005)
29. Lindsey I, "A randomized, controlled trial of fibrin glue vs. conventional treatment for anal fistula", Dis Colon Rectum, 45, pp.1608~1615 (2002)
30. Yamamoto T, "Effect of fecal diversion alone on perianal Crohn’s disease", World J Surg, 24, pp.1258~1262 (2000)
31. Mueller MH, "Risk of fecal diversion in complicated perianal Crohn’s disease", J Gastrointest Surg, 11, pp.529~537 (2007)
32. Galandiuk S, "Perianal Crohn disease: predictors of need for permanent diversion", Ann Surg, 241, pp.796~801 (2005)
33. Kasparek MS, "Long-term quality of life in patients with Crohn’s disease and perianal fistulas: influence of fecal diversion", Dis Colon Rectum, 50, pp.2067~2074 (2007)
34. Rojanasakul A, "Total anal sphincter saving technique for fistula-inano;the ligation of intersphincteric fistula tract", J Med Assoc Thai, 90, pp.581~586 (2007)
35. Bleier JI, "Ligation of the intersphincteric fistula tract: an effective new technique for complex fistulas", Dis Colon Rectum, 53, pp.43~46 (2010)
36. Gingold DS, "A prospective evaluation of the ligation of the intersphincteric tract procedure for complex anal fistula in patients with Crohn’s disease", Ann Surg, 260, pp.1057~1061 (2014)
37. Kamiński JP, "Increasing experience of ligation of the intersphincteric fistula tract for patients with Crohn’s disease: what have we learned?", Colorectal Dis, 19, pp.750~755 (2017)
38. Garcia-Olmo D, "Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial", Dis Colon Rectum, 52, pp.79~86 (2009)
39. de la Portilla F, "Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I", IIa clinical trial, 2013, pp.28, 313~323
40. Lee WY, "Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn’s fistula", Stem Cells, 31, pp.2575~2581 (2013)
41. Cho YB, "Long-term results of adipose-derived stem cell therapy for the treatment of Crohn’s fistula", Stem Cells Transl Med, 4, pp.532~537 (2015)
42. Panés J, "Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial", Lancet, 388, pp.1281~1290 (2016)
43. de la Portilla F, "Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I", IIa clinical trial, 2013, pp.28, 313~323

관련 논문AI추천